Search

everythinglearnresearchcommunity

for

Search:↓

Congenital Triangular Alopecia is a rare, non-scarring hair loss that can be surgically treated in females for cosmetic reasons.

COVID-19 may cause hair loss, often after recovery, with androgenetic alopecia being the most common type.

The man has Temporal Triangular Alopecia, a stable, non-scarring hair loss condition best treated with hair transplantation.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

Platelet-rich plasma, which carries growth factors, could be a promising treatment for non-scarring hair loss, promoting hair growth and density with no major side effects.

Alopecia areata is a skin condition causing hair loss, and its exact cause is unknown, but it may involve biological mechanisms.

Topical immunotherapy, especially with DPCP, is effective for treating severe alopecia areata.

Alopecia areata involves immune response and gene changes affecting hair loss.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Deuruxolitinib is approved to treat severe alopecia areata in adults.

New treatments for alopecia areata show promise but need ongoing use and have infection risks.

Alopecia areata causes patchy hair loss due to the immune system attacking hair follicles.

New hair treatment methods are evolving, with microneedling as a promising technique for hair growth.

Alopecia areata is caused by the immune system attacking hair follicles.

New treatments for Alopecia Areata, like JAK inhibitors, are effective, and future research is exploring advanced therapies.

LC-OCT is a promising tool for diagnosing and monitoring Alopecia areata.

Baricitinib is a promising treatment for alopecia areata.

Hair disorders are complex and varied, including hair loss, excessive growth, color, and shaft issues.

Alopecia areata is a hair loss condition that often starts before age 30 and can affect various body parts, with unpredictable hair regrowth chances.

Alopecia areata in children is caused by the immune system attacking hair follicles due to genetic factors.

Trichoscopy can help diagnose and monitor the progression of dissecting cellulitis.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

The document concludes that diagnosing female hair loss requires careful examination, with treatments varying by condition and psychological support often necessary.

Autoimmune diseases like lupus, dermatomyositis, and scleroderma can cause hair loss and other hair problems, and treatments for these diseases might also affect hair.

Diagnosing alopecia areata is challenging and requires careful examination and various tests to distinguish it from other hair loss types.

Hair loss is a significant challenge with psychological effects, but treatments like minoxidil and finasteride are effective.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Alopecia areata is caused by immune attacks on hair follicles, affecting hair growth and quality of life.

Alopecia areata needs new treatments targeting autoimmune processes due to its emotional impact and variable treatment responses.

JAK inhibitors are effective treatments for alopecia areata.